IN2014MU01312A - - Google Patents

Info

Publication number
IN2014MU01312A
IN2014MU01312A IN1312MU2014A IN2014MU01312A IN 2014MU01312 A IN2014MU01312 A IN 2014MU01312A IN 1312MU2014 A IN1312MU2014 A IN 1312MU2014A IN 2014MU01312 A IN2014MU01312 A IN 2014MU01312A
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Hardik Shah
Original Assignee
Olive Healthcare
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Olive Healthcare filed Critical Olive Healthcare
Priority to IN1312MU2014 priority Critical patent/IN2014MU01312A/en
Publication of IN2014MU01312A publication Critical patent/IN2014MU01312A/en

Links

IN1312MU2014 2014-04-09 2014-04-09 IN2014MU01312A (pl)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN1312MU2014 IN2014MU01312A (pl) 2014-04-09 2014-04-09

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1312MU2014 IN2014MU01312A (pl) 2014-04-09 2014-04-09

Publications (1)

Publication Number Publication Date
IN2014MU01312A true IN2014MU01312A (pl) 2015-10-16

Family

ID=54395729

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1312MU2014 IN2014MU01312A (pl) 2014-04-09 2014-04-09

Country Status (1)

Country Link
IN (1) IN2014MU01312A (pl)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT518311A1 (de) * 2016-03-07 2017-09-15 Gonadosan Gmbh Kombinationspräparat
ITUA20162575A1 (it) * 2016-04-13 2017-10-13 S&R Farm S P A Composizione farmaceutica o nutraceutica per l’uso nel trattamento della sindrome dell’ovaio policistico o di malattie o disturbi correlati ad essa
EP3713552A1 (en) 2017-11-23 2020-09-30 Biosearch S.A. Method for increasing embryo implantation rate in a female subject suffering polycystic ovary syndrome
US12171728B2 (en) 2018-04-16 2024-12-24 S&R Farmaceutici S.P.A. Mixture of resveratrol supported on metal hydroxide and non-supported pure resveratrol for treating female fertility

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT518311A1 (de) * 2016-03-07 2017-09-15 Gonadosan Gmbh Kombinationspräparat
ITUA20162575A1 (it) * 2016-04-13 2017-10-13 S&R Farm S P A Composizione farmaceutica o nutraceutica per l’uso nel trattamento della sindrome dell’ovaio policistico o di malattie o disturbi correlati ad essa
WO2017179012A1 (en) * 2016-04-13 2017-10-19 S&R Farmaceutici S.P.A. Nutraceutical or pharmaceutical composition for use in the treatment of polycystic ovary syndrome or of diseases or disorders related thereto
US11246834B2 (en) 2016-04-13 2022-02-15 S&R Farmaceutici S.P.A. Nutraceutical or pharmaceutical composition for use in the treatment of polycystic ovary syndrome or of diseases or disorders related thereto
EP3713552A1 (en) 2017-11-23 2020-09-30 Biosearch S.A. Method for increasing embryo implantation rate in a female subject suffering polycystic ovary syndrome
US12171728B2 (en) 2018-04-16 2024-12-24 S&R Farmaceutici S.P.A. Mixture of resveratrol supported on metal hydroxide and non-supported pure resveratrol for treating female fertility

Similar Documents

Publication Publication Date Title
BR112016017979A2 (pl)
BR112016017278A2 (pl)
BR112016018948A2 (pl)
BR112016016708A2 (pl)
BR112016017337A2 (pl)
BR112016013761A2 (pl)
BR112016018580A2 (pl)
BR112016018369A2 (pl)
BR112016017083A2 (pl)
BR112016018468A2 (pl)
BR112016011585A2 (pl)
BR112016019248A2 (pl)
BR112016016823A2 (pl)
BR112016018564A2 (pl)
BR112016017660A2 (pl)
BR112016015243A2 (pl)
BR112016016992A2 (pl)
BR112016016268A2 (pl)
BR112016015542A2 (pl)
BR112016017681A2 (pl)
BR112016000228A2 (pl)
BR112016017216A2 (pl)
BR112016017538A2 (pl)
BR112016019471A2 (pl)
BR112016018896A2 (pl)